| Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients Y Meng, H Yang, W Wang, X Tang, C Jiang, Y Shen, W Luo Radiation Oncology 14, 1-8, 2019 | 24 | 2019 |
| GBP1 facilitates indoleamine 2, 3-dioxygenase extracellular secretion to promote the malignant progression of lung cancer Y Meng, W Wang, M Chen, K Chen, X Xia, S Zhou, H Yang Frontiers in Immunology 11, 622467, 2021 | 17 | 2021 |
| Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial? Y Meng, W Luo, H Xu, W Wang, S Zhou, X Tang, Z Li, C Zhou, H Yang Radiotherapy and Oncology 158, 118-124, 2021 | 16 | 2021 |
| Enhanced CT-based radiomics to predict micropapillary pattern within lung invasive adenocarcinoma Y Xu, W Ji, L Hou, S Lin, Y Shi, C Zhou, Y Meng, W Wang, X Chen, ... Frontiers in Oncology 11, 704994, 2021 | 12 | 2021 |
| Reduced PHLPP expression leads to EGFR-TKI resistance in lung cancer by activating PI3K-AKT and MAPK-ERK dual signaling W Wang, X Xia, K Chen, M Chen, Y Meng, D Lv, H Yang Frontiers in Oncology 11, 665045, 2021 | 12 | 2021 |
| Intermediate dose-volume parameters, not low-dose bath, is superior to predict radiation pneumonitis for lung cancer treated with intensity-modulated radiotherapy Y Meng, W Luo, W Wang, C Zhou, S Zhou, X Tang, L Hou, FMS Kong, ... Frontiers in oncology 10, 584756, 2020 | 11 | 2020 |
| Endostar improved efficacy of concurrent chemoradiotherapy with vinorelbine plus carboplatin in locally advanced lung squamous cell carcinoma patients with high serum Lp (a … H Xu, D Lv, Y Meng, M Wang, W Wang, C Zhou, S Zhou, X Chen, H Yang Annals of Palliative Medicine 9 (2), 29807-29307, 2020 | 11 | 2020 |
| The prognostic value of circulating lymphocyte counts and ABO blood group in lung cancer stereotactic body radiation therapy: a retrospective study M Chen, K Chen, S Li, Y Meng, Y Shi, X Chen, H Yang Journal of thoracic disease 14 (2), 494, 2022 | 7 | 2022 |
| Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone? X Tang, Y Shen, Y Meng, L Hou, C Zhou, C Yu, H Jia, W Wang, G Ren, ... Annals of palliative medicine, 2021 | 6 | 2021 |
| FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L S Zhou, M Zhang, C Zhou, Y Meng, H Yang, W Ye Frontiers in Oncology 11, 660955, 2021 | 4 | 2021 |
| CT-based radiomics nomogram may predict who can benefit from adaptive radiotherapy in patients with local advanced-NSCLC patients C Zhou, L Hou, X Tang, C Liu, Y Meng, H Jia, H Yang, S Zhou Radiotherapy and Oncology 183, 109637, 2023 | 3 | 2023 |
| Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study Y Shi, H Xu, WY Raynor, J Ding, L Lin, C Zhou, W Wang, Y Meng, X Wu, ... Life 12 (12), 1954, 2022 | 3 | 2022 |
| The critical components for effective adaptive radiotherapy in patients with unresectable non-small-cell lung cancer: who, when and how S Zhou, Y Meng, X Sun, Z Jin, W Feng, H Yang Future Oncology 18 (31), 3551-3562, 2022 | 3 | 2022 |
| Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis S Li, K Chen, M Yang, SS Hlaing, M Chen, P Gu, Y Meng, H Yang Frontiers in Immunology 13, 991431, 2022 | 3 | 2022 |
| A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma X Wang, Y Meng, C Liu, H Yang, S Zhou Journal of Oncology 2022, 2022 | 3 | 2022 |
| Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiation Therapy in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Y Meng, H Sun, S Wang, H Yang International Journal of Radiation Oncology* Biology* Physics, 2023 | 2 | 2023 |
| Synergistic antitumor effects of anlotinib combined with oral 5-fluorouracil/S-1 via inhibiting Src/AKT signaling pathway in small-cell lung cancer X Xia, W Pi, Y Lan, X Wu, D Lv, Y Meng, H Yang, W Wang Analytical Cellular Pathology 2022, 2022 | 2 | 2022 |
| P2. 01-124 SIB-IMRT in Symptomatic Brain Metastases for NSCLC: A Randomized Controlled Study of WBRT Comparing 25Gy and 30Gy J Zhu, Q Dong, W Wang, X Tang, Y Meng, F Kong, H Yang Journal of Thoracic Oncology 13 (10), S712-S713, 2018 | 2 | 2018 |
| P1. 04-69 Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer Y Shen, Y Meng, X Tang, P Gu, C Yu, W Wang, F Kong, H Yang Journal of Thoracic Oncology 14 (10), S468, 2019 | 1 | 2019 |
| Dose calibration uncertainty and plan-specific dose calibration for IMRT QA W Luo, Y Meng, SB Westlund Biomedical Physics & Engineering Express 5 (1), 015024, 2018 | 1 | 2018 |
